Clinical Case Discussion: Treating an Adolescent With Marijuana Use Disorder
Expert clinicians discussed the assessment and management of an adolescent marijuana use disorder case, sharing clinical reasoning and treatment recommendations.
Quick Facts
What This Study Found
This clinical case conference presented a real adolescent patient with marijuana use disorder to expert clinicians. The experts shared their diagnostic reasoning, assessment approach, and treatment recommendations in response to the case details.
The format allowed different clinical perspectives to be presented and discussed, illustrating how experienced clinicians approach adolescent marijuana use disorders in practice.
Key Numbers
No specific quantitative data were presented. The article focused on clinical reasoning rather than research findings.
How They Did This
Clinical case conference format: a real patient case was presented to expert clinicians who provided their reasoning and recommendations, followed by a summary of the clinical discussion.
Why This Research Matters
Clinical case conferences bridge the gap between research evidence and real-world practice. They show how guidelines and evidence are applied to individual patients and highlight areas of clinical uncertainty.
The Bigger Picture
Adolescent marijuana use disorder is a growing clinical challenge as cannabis becomes more available. The lack of FDA-approved medications for cannabis use disorder makes behavioral and psychosocial approaches particularly important.
What This Study Doesn't Tell Us
Case conferences reflect expert opinion on a single case and do not constitute clinical trial evidence. The recommendations may not apply to all adolescent patients with marijuana use disorder.
Questions This Raises
- ?What are the most effective treatments for adolescent marijuana use disorder?
- ?How should clinicians balance harm reduction with abstinence goals?
Trust & Context
- Key Stat:
- Expert case discussion on adolescent marijuana use disorder management
- Evidence Grade:
- This is a clinical case conference presenting expert opinion rather than research data.
- Study Age:
- Published in 2016. Treatment approaches for adolescent cannabis use disorder continue to evolve.
- Original Title:
- Weeding Out the Truth: Adolescents and Cannabis: Case and Discussion.
- Published In:
- Journal of addiction medicine, 10(2), 83-8 (2016)
- Authors:
- Caspersen, Shannon, Tau, Gregory Z(2), Ammerman, Seth(2)
- Database ID:
- RTHC-01123
Evidence Hierarchy
Describes what happened to one person or a small group.
What do these levels mean? →Frequently Asked Questions
What treatments are available for teen marijuana use disorder?
Currently, there are no FDA-approved medications for cannabis use disorder. Treatment typically involves behavioral approaches such as motivational enhancement therapy, cognitive behavioral therapy, and family-based interventions.
How common is marijuana use disorder in teens?
Rates vary by study, but adolescents who use cannabis regularly have a significant risk of developing use disorder. Early-onset and frequent use are associated with higher risk.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-01123APA
Caspersen, Shannon; Tau, Gregory Z; Ammerman, Seth. (2016). Weeding Out the Truth: Adolescents and Cannabis: Case and Discussion.. Journal of addiction medicine, 10(2), 83-8. https://doi.org/10.1097/ADM.0000000000000195
MLA
Caspersen, Shannon, et al. "Weeding Out the Truth: Adolescents and Cannabis: Case and Discussion.." Journal of addiction medicine, 2016. https://doi.org/10.1097/ADM.0000000000000195
RethinkTHC
RethinkTHC Research Database. "Weeding Out the Truth: Adolescents and Cannabis: Case and Di..." RTHC-01123. Retrieved from https://rethinkthc.com/research/caspersen-2016-weeding-out-the-truth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.